A Critical Role for CARD9 in Intestinal Microbiota Modulation and Colorectal Malignancies

Area of Science:

• Immunology
• Oncology
• Microbiome Research

Background:

• Caspase Recruitment Domain Family Member 9 (CARD9) is vital for innate immune responses.
• Dysregulation of CARD9 is increasingly recognized as a risk factor in colorectal cancer (CRC) development and progression.

Purpose of the Study:

• To review and elucidate the multifaceted roles of CARD9 in the context of colorectal cancer.
• To highlight CARD9's involvement in host-microbe interactions, gut microbiota metabolism, and immune responses within CRC.

Main Methods:

• Literature review of recent studies on CARD9 function in immunity and cancer.
• Analysis of CARD9's impact on gut microbiota composition and function.
• Examination of CARD9's role in the induction of antifungal antibodies.

Main Results:

• CARD9 dysregulation disrupts the delicate balance between the host and gut microbes.
• CARD9 influences the metabolic activity of the gut microbiota.
• CARD9 signaling contributes to the generation of systemic immunoglobulin G (IgG) antifungal antibodies in CRC.

Conclusions:

• CARD9 plays a significant role in CRC pathogenesis through its modulation of the gut microbiome and immune system.
• These findings offer potential therapeutic targets and strategies for CRC intervention.
• CARD9-related pathways may inform the development of novel vaccines for colorectal cancer.